-
Humoral and cellular immune response after COVID-19 vaccination in patients with sickle cell disease on hydroxyurea
Haggenburg, S., Pothast, C. R., Hofsink, Q., Haverkate, N. J. E., Bhoekhan, M. S., Claireaux, M., van Binnendijk, R. S., den Hartog, G., Lissenberg-Witte, B. I., de Vries, R. D., Van Tuijn, C. F. J., Biemond, B. J., Nur, E., GeurtsvanKessel, C., Mutsaers, P. G. N. J., Broers, A. E. C., Goorhuis, A., Nijhof, I. S., van Gils, M. & Heemskerk, M. H. M. & 2 others, , 26 Nov 2025, (E-pub ahead of print) In: BLOOD ADVANCES.Research output: Contribution to journal › Article › Academic › peer-review
-
Long-term Immunogenicity and Boostability of the 13-valent Pneumococcal Conjugate Vaccine Followed by the 23-valent Pneumococcal Polysaccharide Vaccine in Adults Receiving Immunosuppressive Therapy and Adults With HIV-3-year Follow-up of a Prospective Cohort Study
Schnyder, J. L., Haggenburg, S., Garcia Garrido, H. M., Reiners, A., Meek, B., Grobusch, M. P. & Goorhuis, A., 15 Nov 2025, In: Clinical infectious diseases. 81, 5, p. e432-e440Research output: Contribution to journal › Article › Academic › peer-review
-
T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines
Pothast, C. R., Hofsink, Q., Haggenburg, S., Dijkland, R. C., van de Meent, M., van Dijk, K., Bhoekhan, M. S., Haverkate, N. J. E., van Meerloo, J., Falkenburg, J. H. F., de Groen, R. A. L., Broers, A. E. C., van Doesum, J. A., van Binnendijk, R. S., den Hartog, G., Lissenberg-Witte, B. I., Kater, A. P., Smits, G. P., Wouters, D. & van Leeuwen, E. M. M. & 13 others, , 1 Nov 2025, In: Haematologica. 110, 11, p. 2799-2805 7 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
